Veterans Affairs News and Research

RSS

Bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy

In a small study from a referral center for dermatology, most patients receiving prolonged oral corticosteroids for chronic skin diseases were not receiving therapies to prevent osteoporosis that may be caused by the drug, according to an article in the January issue of Archives of Dermatology.

16 Jan 2006

Acetazolamide improves central sleep apnea in heart failure

Since sleep apnea is associated with heart failure, patients who take a single dose of acetazolamide - a mild diuretic and respiratory stimulant - before going to bed exhibit less sleep apnea, improved blood oxygen levels and fewer daytime symptoms of sleepiness.

16 Jan 2006

Value of prostate tests dubious

According to new research, men screened for prostate cancer using blood tests or digital examinations die of the disease at much the same rate as those who were not checked.

10 Jan 2006

Screening for prostate cancer may not reduce risk of death

Screening men for prostate cancer may not reduce their risk for dying, according to a new study in the January 9 issue of Archives of Internal Medicine.

9 Jan 2006

The effectiveness of screening for prostate cancer

A screening test for prostate cancer that measures prostate-specific antigen (PSA) levels does not improve survival, researchers at the Veterans Affairs (VA) Connecticut Healthcare System and Yale School of Medicine report in the January 9 Archives of Internal Medicine.

9 Jan 2006

Americans don't need to pay the highest prices in the world for prescription drugs!

A study of drug costs around the world revealed proven methods that could be used to reduce costs in the United States, according to a researcher from Wake Forest University School of Medicine.

6 Jan 2006

Gulf War Syndrome more prevalent in first Persian Gulf War veterans

Comparing veterans deployed in the first Persian Gulf War and veterans deployed elsewhere at the same time has revealed veterans who served in the Persian Gulf have nearly twice the prevalence of chronic multi-symptom illness (CMI), a cluster of symptoms similar to a set of conditions often called Gulf War Syndrome.

5 Jan 2006

Researchers discover how a gene linked to Parkinson’s disease can keep brain cells alive

Researchers at the University of Colorado at Denver and Health Sciences Center’s School of Medicine have uncovered how a gene linked to Parkinson’s disease can keep brain cells alive. The results suggest the possibility for new drugs that might regulate the gene and protect Parkinson’s patients from further cell damage.

29 Dec 2005

Fee-for-service associated with a significantly higher rate of cataract surgery

A system in which physicians are reimbursed for each procedure they perform (fee-for-service) is associated with a significantly higher rate of cataract surgery and related surgical costs, compared to a system in which physicians receive a lump sum for each patient they manage (contact capitation), according to a study in the December issue of Archives of Ophthalmology.

13 Dec 2005

Depressed heart patients skip medications

Recent studies conducted at the San Francisco VA Medical Center suggest two possible mechanisms for the widely recognized link between depression and adverse outcomes in patients with coronary heart disease: lack of adherence to medication regimens and increased levels of norepinephrine, a stress hormone.

2 Dec 2005

Study links low level of response (LR) to alcohol to an area on chromosome 10

How a person "feels" the effects of alcohol is, in part, genetically influenced and relates to their risk for developing alcoholism.

28 Nov 2005

Thrombospondin (TSP-1) can cause kidney failure when normal blood flow is disrupted

Scientists led by a University of Cincinnati (UC) kidney expert have found that a naturally occurring protein that normally fights cancer cells can also cause severe kidney failure when normal blood flow is disrupted.

26 Nov 2005

Drug pravastatin may provide a previously unknown cardiovascular benefit

The drug pravastatin, which is used widely to decrease high cholesterol, may provide a previously unknown cardiovascular benefit in addition to lowering lipids.

20 Nov 2005

Lowering calorie intake may help Parkinson's disease

A new Oregon Health & Science University and Portland Veterans Affairs Medical Center study suggests that early-stage Parkinson's disease patients who lower their calorie intake may boost levels of an essential brain chemical lost from the neurodegenerative disorder.

20 Nov 2005

The Medicare Drug Benefit: A Prescription for Confusion

If many seniors are scratching their heads about the new Medicare prescription drug plan, so are the experts.

20 Nov 2005

Obstructive sleep apnea significantly increases the risk of stroke

An observational study of more than 1,000 patients at the Yale Center for Sleep Medicine found that obstructive sleep apnea significantly increases the risk of stroke or death from any cause, and that the risk is linked to sleep apnea severity.

13 Nov 2005

Cholesterol lowering drugs do not appear to decrease the risk of melanoma

No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.

7 Nov 2005

America will not have a high-quality health system if equal attention is not given to mental health issues and substance-use problems

Without a comprehensive strategy to improve the quality of health care for people with mental conditions and alcohol or drug problems, high-quality care in the nation's overall health system and better health for the public are goals that will remain unmet

7 Nov 2005

Type 2 diabetes and depression can be a fatal mix

Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.

27 Oct 2005

Antisense molecules may hold promise in treating brain chemical problems such as Alzheimer's

Saint Louis University research shows a new class of drugs may hold promise in treating brain chemical problems such as Alzheimer's disease, says the principal investigator of research published in an early on-line version of Peptides.

25 Oct 2005